AIHealthcare Analytics

Knowledge Wiki

Wiki › AI, Intellectual Property, and Human Rights in European Health Systems

AI, Intellectual Property, and Human Rights in European Health Systems

OVERVIEW
Rev 1 Jul 30, 2026 12:13 UTC 4 sources

A study synthesizing 53 laws and treaties mapping the intellectual property (IP) landscape for AI in European health systems identifies significant tensions between IP protection and health-focused human rights. A wide variety of AI components—datasets, software, hardware, outputs, model architectures, databases, and graphical user interfaces—can be subject to IP protection. However, the interpretation of limitations and exceptions to IP rights is left to courts, creating legal uncertainty that affects AI accessibility and accountability in healthcare. The analysis reveals tensions between promoting innovation and ensuring accessibility, quality, and equity in health systems, as well as between human rights ideals and the protection of European digital sovereignty. IP rights and human rights "often pursue conflicting objectives and may involve trade-offs," with future research needed to reconcile these objectives and foster solidarity in sharing risks and benefits among stakeholders. A complementary analysis of EU Public Procurement Directive (PPD) mechanisms argues that procurement can complement the EU AI Act and Medical Device Regulation to strengthen quality assurance when AI tools are adopted in healthcare. Beyond CE-marking, procurement should require evidence of clinical relevance, context-specific documentation, transparency, and clearly defined quality criteria. A related paper on the right to health argues that if medical AI can fulfill duties to provide access to…

Sources: harvested
🔒

Subscribe to read full wiki analysis

Full wiki content — including source provenance, contradiction tracking, related pages, and analyst notes — is available to Subscriber members.

View Plans & Subscribe

New users get a 7-day trial — no credit card required.

← Back to Wiki Index